Despite the only 1.3 fold increase in SLC7A5/LAT1 level, the results as indicated by the adjusted_ P value is highly significant.
← all excerpts
Inhibition of eEF2K synergizes with glutaminase inhibitors or 4EBP1 depletion to suppress growth of triple-negative breast cancer cells.
1
—
—